0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Newborn and Prenatal Genetic Testing Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-31E8293
Home | Market Reports | Health| Reproductive Health
Global Newborn and Prenatal Genetic Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Newborn and Prenatal Genetic Testing Market Research Report 2024

Code: QYRE-Auto-31E8293
Report
January 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Newborn and Prenatal Genetic Testing Market

Newborn and prenatal genetic testing is to judge the underlying genetic disease of the newborn and fetus.
The global Newborn and Prenatal Genetic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Due to the increased prevalence of genetic diseases and chromosomal abnormalities, the need for early screening for prenatal and newborn defects has increased. According to the Centers for Disease Control and Prevention (CDC), birth defects occur in about 3% of the total number of live births worldwide, leading to infant death.
This report aims to provide a comprehensive presentation of the global market for Newborn and Prenatal Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn and Prenatal Genetic Testing.

Report Scope

The Newborn and Prenatal Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newborn and Prenatal Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn and Prenatal Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Newborn and Prenatal Genetic Testing Market Report

Report Metric Details
Report Name Newborn and Prenatal Genetic Testing Market
Segment by Type
  • PCR
  • FISH
  • aCGH
  • NIPT
  • MSS
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Perkin Elmer, Verinata Health, Sequenom, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc., Illumina, Inc., Ariosa Diagnostics, BGI, CapitalBio MedLab
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Newborn and Prenatal Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Newborn and Prenatal Genetic Testing Market report?

Ans: The main players in the Newborn and Prenatal Genetic Testing Market are Perkin Elmer, Verinata Health, Sequenom, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc., Illumina, Inc., Ariosa Diagnostics, BGI, CapitalBio MedLab

What are the Application segmentation covered in the Newborn and Prenatal Genetic Testing Market report?

Ans: The Applications covered in the Newborn and Prenatal Genetic Testing Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Newborn and Prenatal Genetic Testing Market report?

Ans: The Types covered in the Newborn and Prenatal Genetic Testing Market report are PCR, FISH, aCGH, NIPT, MSS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn and Prenatal Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 FISH
1.2.4 aCGH
1.2.5 NIPT
1.2.6 MSS
1.3 Market by Application
1.3.1 Global Newborn and Prenatal Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn and Prenatal Genetic Testing Market Perspective (2019-2030)
2.2 Newborn and Prenatal Genetic Testing Growth Trends by Region
2.2.1 Global Newborn and Prenatal Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Newborn and Prenatal Genetic Testing Historic Market Size by Region (2019-2024)
2.2.3 Newborn and Prenatal Genetic Testing Forecasted Market Size by Region (2025-2030)
2.3 Newborn and Prenatal Genetic Testing Market Dynamics
2.3.1 Newborn and Prenatal Genetic Testing Industry Trends
2.3.2 Newborn and Prenatal Genetic Testing Market Drivers
2.3.3 Newborn and Prenatal Genetic Testing Market Challenges
2.3.4 Newborn and Prenatal Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn and Prenatal Genetic Testing Players by Revenue
3.1.1 Global Top Newborn and Prenatal Genetic Testing Players by Revenue (2019-2024)
3.1.2 Global Newborn and Prenatal Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Newborn and Prenatal Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn and Prenatal Genetic Testing Revenue
3.4 Global Newborn and Prenatal Genetic Testing Market Concentration Ratio
3.4.1 Global Newborn and Prenatal Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn and Prenatal Genetic Testing Revenue in 2023
3.5 Newborn and Prenatal Genetic Testing Key Players Head office and Area Served
3.6 Key Players Newborn and Prenatal Genetic Testing Product Solution and Service
3.7 Date of Enter into Newborn and Prenatal Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn and Prenatal Genetic Testing Breakdown Data by Type
4.1 Global Newborn and Prenatal Genetic Testing Historic Market Size by Type (2019-2024)
4.2 Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Type (2025-2030)
5 Newborn and Prenatal Genetic Testing Breakdown Data by Application
5.1 Global Newborn and Prenatal Genetic Testing Historic Market Size by Application (2019-2024)
5.2 Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Newborn and Prenatal Genetic Testing Market Size (2019-2030)
6.2 North America Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024)
6.4 North America Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn and Prenatal Genetic Testing Market Size (2019-2030)
7.2 Europe Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024)
7.4 Europe Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size (2019-2030)
8.2 Asia-Pacific Newborn and Prenatal Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn and Prenatal Genetic Testing Market Size (2019-2030)
9.2 Latin America Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024)
9.4 Latin America Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size (2019-2030)
10.2 Middle East & Africa Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perkin Elmer
11.1.1 Perkin Elmer Company Detail
11.1.2 Perkin Elmer Business Overview
11.1.3 Perkin Elmer Newborn and Prenatal Genetic Testing Introduction
11.1.4 Perkin Elmer Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.1.5 Perkin Elmer Recent Development
11.2 Verinata Health
11.2.1 Verinata Health Company Detail
11.2.2 Verinata Health Business Overview
11.2.3 Verinata Health Newborn and Prenatal Genetic Testing Introduction
11.2.4 Verinata Health Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.2.5 Verinata Health Recent Development
11.3 Sequenom, Inc.
11.3.1 Sequenom, Inc. Company Detail
11.3.2 Sequenom, Inc. Business Overview
11.3.3 Sequenom, Inc. Newborn and Prenatal Genetic Testing Introduction
11.3.4 Sequenom, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.3.5 Sequenom, Inc. Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Detail
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Introduction
11.4.4 Agilent Technologies, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Detail
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Natera, Inc.
11.6.1 Natera, Inc. Company Detail
11.6.2 Natera, Inc. Business Overview
11.6.3 Natera, Inc. Newborn and Prenatal Genetic Testing Introduction
11.6.4 Natera, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.6.5 Natera, Inc. Recent Development
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Detail
11.7.2 Illumina, Inc. Business Overview
11.7.3 Illumina, Inc. Newborn and Prenatal Genetic Testing Introduction
11.7.4 Illumina, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.7.5 Illumina, Inc. Recent Development
11.8 Ariosa Diagnostics
11.8.1 Ariosa Diagnostics Company Detail
11.8.2 Ariosa Diagnostics Business Overview
11.8.3 Ariosa Diagnostics Newborn and Prenatal Genetic Testing Introduction
11.8.4 Ariosa Diagnostics Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.8.5 Ariosa Diagnostics Recent Development
11.9 BGI
11.9.1 BGI Company Detail
11.9.2 BGI Business Overview
11.9.3 BGI Newborn and Prenatal Genetic Testing Introduction
11.9.4 BGI Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.9.5 BGI Recent Development
11.10 CapitalBio MedLab
11.10.1 CapitalBio MedLab Company Detail
11.10.2 CapitalBio MedLab Business Overview
11.10.3 CapitalBio MedLab Newborn and Prenatal Genetic Testing Introduction
11.10.4 CapitalBio MedLab Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.10.5 CapitalBio MedLab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Newborn and Prenatal Genetic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of PCR
    Table 3. Key Players of FISH
    Table 4. Key Players of aCGH
    Table 5. Key Players of NIPT
    Table 6. Key Players of MSS
    Table 7. Global Newborn and Prenatal Genetic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Newborn and Prenatal Genetic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Newborn and Prenatal Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Newborn and Prenatal Genetic Testing Market Share by Region (2019-2024)
    Table 11. Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Newborn and Prenatal Genetic Testing Market Share by Region (2025-2030)
    Table 13. Newborn and Prenatal Genetic Testing Market Trends
    Table 14. Newborn and Prenatal Genetic Testing Market Drivers
    Table 15. Newborn and Prenatal Genetic Testing Market Challenges
    Table 16. Newborn and Prenatal Genetic Testing Market Restraints
    Table 17. Global Newborn and Prenatal Genetic Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Newborn and Prenatal Genetic Testing Market Share by Players (2019-2024)
    Table 19. Global Top Newborn and Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn and Prenatal Genetic Testing as of 2023)
    Table 20. Ranking of Global Top Newborn and Prenatal Genetic Testing Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Newborn and Prenatal Genetic Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Newborn and Prenatal Genetic Testing Product Solution and Service
    Table 24. Date of Enter into Newborn and Prenatal Genetic Testing Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Newborn and Prenatal Genetic Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Type (2019-2024)
    Table 28. Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Type (2025-2030)
    Table 30. Global Newborn and Prenatal Genetic Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Application (2019-2024)
    Table 32. Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Application (2025-2030)
    Table 34. North America Newborn and Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Newborn and Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Newborn and Prenatal Genetic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Newborn and Prenatal Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Newborn and Prenatal Genetic Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Newborn and Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Newborn and Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Perkin Elmer Company Detail
    Table 50. Perkin Elmer Business Overview
    Table 51. Perkin Elmer Newborn and Prenatal Genetic Testing Product
    Table 52. Perkin Elmer Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 53. Perkin Elmer Recent Development
    Table 54. Verinata Health Company Detail
    Table 55. Verinata Health Business Overview
    Table 56. Verinata Health Newborn and Prenatal Genetic Testing Product
    Table 57. Verinata Health Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 58. Verinata Health Recent Development
    Table 59. Sequenom, Inc. Company Detail
    Table 60. Sequenom, Inc. Business Overview
    Table 61. Sequenom, Inc. Newborn and Prenatal Genetic Testing Product
    Table 62. Sequenom, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 63. Sequenom, Inc. Recent Development
    Table 64. Agilent Technologies, Inc. Company Detail
    Table 65. Agilent Technologies, Inc. Business Overview
    Table 66. Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Product
    Table 67. Agilent Technologies, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 68. Agilent Technologies, Inc. Recent Development
    Table 69. Bio-Rad Laboratories, Inc. Company Detail
    Table 70. Bio-Rad Laboratories, Inc. Business Overview
    Table 71. Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Product
    Table 72. Bio-Rad Laboratories, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 73. Bio-Rad Laboratories, Inc. Recent Development
    Table 74. Natera, Inc. Company Detail
    Table 75. Natera, Inc. Business Overview
    Table 76. Natera, Inc. Newborn and Prenatal Genetic Testing Product
    Table 77. Natera, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 78. Natera, Inc. Recent Development
    Table 79. Illumina, Inc. Company Detail
    Table 80. Illumina, Inc. Business Overview
    Table 81. Illumina, Inc. Newborn and Prenatal Genetic Testing Product
    Table 82. Illumina, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 83. Illumina, Inc. Recent Development
    Table 84. Ariosa Diagnostics Company Detail
    Table 85. Ariosa Diagnostics Business Overview
    Table 86. Ariosa Diagnostics Newborn and Prenatal Genetic Testing Product
    Table 87. Ariosa Diagnostics Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 88. Ariosa Diagnostics Recent Development
    Table 89. BGI Company Detail
    Table 90. BGI Business Overview
    Table 91. BGI Newborn and Prenatal Genetic Testing Product
    Table 92. BGI Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 93. BGI Recent Development
    Table 94. CapitalBio MedLab Company Detail
    Table 95. CapitalBio MedLab Business Overview
    Table 96. CapitalBio MedLab Newborn and Prenatal Genetic Testing Product
    Table 97. CapitalBio MedLab Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024) & (US$ Million)
    Table 98. CapitalBio MedLab Recent Development
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Newborn and Prenatal Genetic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Newborn and Prenatal Genetic Testing Market Share by Type: 2023 VS 2030
    Figure 3. PCR Features
    Figure 4. FISH Features
    Figure 5. aCGH Features
    Figure 6. NIPT Features
    Figure 7. MSS Features
    Figure 8. Global Newborn and Prenatal Genetic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Newborn and Prenatal Genetic Testing Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Others Case Studies
    Figure 13. Newborn and Prenatal Genetic Testing Report Years Considered
    Figure 14. Global Newborn and Prenatal Genetic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Newborn and Prenatal Genetic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Newborn and Prenatal Genetic Testing Market Share by Region: 2023 VS 2030
    Figure 17. Global Newborn and Prenatal Genetic Testing Market Share by Players in 2023
    Figure 18. Global Top Newborn and Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn and Prenatal Genetic Testing as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Newborn and Prenatal Genetic Testing Revenue in 2023
    Figure 20. North America Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Newborn and Prenatal Genetic Testing Market Share by Country (2019-2030)
    Figure 22. United States Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Newborn and Prenatal Genetic Testing Market Share by Country (2019-2030)
    Figure 26. Germany Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Newborn and Prenatal Genetic Testing Market Share by Region (2019-2030)
    Figure 34. China Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Newborn and Prenatal Genetic Testing Market Share by Country (2019-2030)
    Figure 42. Mexico Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Newborn and Prenatal Genetic Testing Market Share by Country (2019-2030)
    Figure 46. Turkey Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Newborn and Prenatal Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Perkin Elmer Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 49. Verinata Health Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 50. Sequenom, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 51. Agilent Technologies, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 52. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 53. Natera, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 54. Illumina, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 55. Ariosa Diagnostics Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 56. BGI Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 57. CapitalBio MedLab Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2019-2024)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS